CD4 and eosinophilic esophagitis: Patients enrolled in the phase IIa study of milk EPIT for EoE were separately enrolled into this optional research investigation in order to test the hypothesis that alterations in human peripheral CD4+ T‐cell responses underlie the mechanism of epicutaneous desensitisation in EoE patients.17